VRTX Vertex Pharmaceuticals Incorpor
$530.37▲ +1.79%
Healthcare
Other
Volume 588.0K
Avg Volume (10D) 1.44M
Key Metrics & Fundamentals
Market Cap
$134.43B
P/E Ratio
30.3
Div Yield
0.00%
52W Range
403.16 - 560.25
% vs 50 MA
-0.39%
% vs 200 MA
9.03%
RSI-14
53.4
MACD Histogram
+2.6300
Beta (1Y vs SPY)
0.50
Free Cash Flow
$1.01B
Gross Rev
$3.33B
Gross Profit
$2.84B
EBITDA
$1.35B
COGS
$489.20M
Operating Exp
$1.58B
Operating Income
$1.27B
EBIT
$1.27B
Pretax Income
$1.39B
Net Income
$1.10B
EPS (Diluted)
4.31
Price & Volume History
Loading chart…
Recent News
Biogen Crushes Earnings Estimates. As Old Blockbusters Fade, New Bets Pick Up the Slack.
Barrons.com · Oct 28, 2026 10:23 AM ET
Royalty Pharma (RPRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Zacks · Oct 28, 2026 9:00 AM ET
Ahead of Vertex (VRTX) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Zacks · Oct 28, 2026 8:15 AM ET
What Would Slower New Drug Sales Do To Vertex Stock?
Trefis · Oct 28, 2026 8:01 AM ET
Here is What to Know Beyond Why Vertex Pharmaceuticals Incorporated (VRTX) is a Trending Stock
Zacks · Oct 28, 2026 8:00 AM ET
What iShares Biotechnology ETF (IBB) Bought: Gilead Leads on Monday
GuruFocus.com · Oct 28, 2026 7:05 AM ET
Enanta Pharmaceuticals Announces Planned Retirement of Longstanding Chief Executive Officer Jay R. Luly, Ph.D. After 23 Years of Company Leadership
Business Wire · Oct 28, 2026 7:00 AM ET
Has The Story Under Krystal Biotech Stock Run Out?
Trefis · Oct 28, 2026 4:22 AM ET
Amgen vs. Vertex Pharmaceuticals: Massive Pharmaceutical Scale vs. Steady Drug Revenue
Motley Fool · Oct 27, 2026 3:45 PM ET
Vertex Gears Up to Report Q3 Earnings: Is a Beat in the Cards?
Zacks · Oct 27, 2026 10:15 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See VRTX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.